Mednext Pharma Private Limited, a active private limited company, was established on 03 February 2009 in Navi Mumbai, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24110MH2009PTC190076. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹5.05 M.
It upholds a compliant status. Its leadership includes Anil Kumar Vyas (Director), Neelam Vyas (Director). Past directors included Harsh Bulla, Alex Charles Fernandes. It holds ₹19.82 Cr open charges and ₹1.10 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No. 901, Sai Anant, Smit Chs, Pl-12, Sect-30, Vashi,, Navi Mumbai, Maharashtra, 410209.
U24110MH2009PTC190076
190076
03 February 2009
₹1.50 Cr
₹5.05 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Mednext Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Kumar Vyas | Director | 03 Feb 2009 | Current |
| Neelam Vyas | Director | 04 Mar 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2010 | Past |
| Pramod Abcsdd | Director | 16 Apr 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mednext Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.71% decrease. The company also saw a substantial improvement in profitability, with a 37.97% increase in profit. The company's net worth moved up by a moderate rise of 1.26%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Mednext Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹198,168,000.00
₹11,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Mar 2022 | Others | ₹16.59 Cr | Open |
| 19 Feb 2016 | Axis Bank Limited | ₹2.23 Cr | Open |
| 16 Jan 2015 | Indusland Bank Limited | ₹1.00 Cr | Open |
| 21 Oct 2013 | Canara Bank | ₹1.10 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Mednext Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mednext Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mednext Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Mednext Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Mednext Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity A charge with Others of Rs. 16.59 Cr registered on 16 Mar 2022 with Charge ID 100558565 was modified on 13 Mar 2023. was completed.
Progress on A charge with Others amounted to Rs. 16.59 Cr with Charge ID 100558565 was registered on 16 Mar 2022. was documented.
A charge registered on 21 Oct 2013 via Charge ID 10465501 with Canara Bank was fully satisfied on 12 Mar 2018. was recorded as a recent event.
Progress on Neelam Vyas was appointed as a Director was appointed as a Director on 04 Mar 2017 & has been associated with this company since 8 years 9 months . was documented.
The CIN of Mednext Pharma Private Limited is U24110MH2009PTC190076.
Mednext Pharma Private Limited is headquartered at Flat No. 901, Sai Anant, Smit Chs, Pl-12, Sect-30, Vashi,, Navi Mumbai, Maharashtra, 410209.
Mednext Pharma Private Limited was incorporated on 03 February 2009.
The current directors of Mednext Pharma Private Limited are
The primary industry of Mednext Pharma Private Limited is Trade.
Mednext Pharma Private Limited is unlisted.
The authorized capital of Mednext Pharma Private Limited is ₹1.50 Cr, and the paid-up capital is ₹5.05 M.
The compliance status of Mednext Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX